RTW Investments

Rocket Pharmaceuticals

Cranbury

Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.

UroGen Pharma

Princeton

UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies.

Milestone Pharmaceuticals

Montreal

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

Stoke Therapeutics

Bedford

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.

LENZ THERAPEUTICS

San Diego

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Magnolia Medical Technologies

Seattle

Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests.

Verastem Oncology

Needham

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

CORXEL Pharmaceuticals

Berkeley Heights

CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.

REGENXBIO

Rockville

REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.

Allakos

Redwood City

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Lycia Therapeutics

South San Francisco

Lycia is a Series B biotech company built on a platform developed by academic founder Professor Carolyn Bertozzi at Stanford, arising from Stanford research, with potential to deliver next-generation therapeutics for difficult-to-treat dise